General Information of Drug (ID: DMPR0LU)

Drug Name
CEP-41750
Indication
Disease Entry ICD 11 Status REF
Rheumatoid arthritis FA20 Phase 3 [1]
Cross-matching ID
TTD ID
D09WRG

References

1 ClinicalTrials.gov (NCT02032004) The Purpose of This Study is to Evaluate the Efficacy and Safety of a Allogeneic Mesenchymal Precursor Cells (CEP-41750) for the Treatment of Chronic Heart Failure.. U.S. National Institutes of Health.